Effects of a disease management program in individuals with alpha-1 antitrypsin deficiency

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 6, Issue 1, 2009, Pages 31-40

  Campos, Michael A ^a   Alazemi, Saleh ^a   Zhang, Guoyan ^b   Wanner, Adam ^a   Sandhaus, Robert A ^c,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Miami Dade Health Department   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d AlphaNet   (United States)

Author keywords

Alpha 1 antitrypsin deficiency; Chronic obstructive pulmonary disease; Disease management; Quality of life

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; STEROID; THEOPHYLLINE;

ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; FEMALE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; ST GEORGE RESPIRATORY QUESTIONNAIRE; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; ALPHA 1-ANTITRYPSIN DEFICIENCY; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TEACHING MATERIALS;

EID: 61649086692     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550802607410     Document Type: Article

References (32)

1. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C. Pulmonary rehabilitation: Joint accp/aacvpr evidence-based clinical practice guidelines. Chest 2007; 131:4S-42S.
2. Hill NS. Pulmonary rehabilitation. Proc Am Thorac Soc 2006; 3:66-74.
3. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: A disease-specific self-management intervention. Arch Intern Med 2003; 163:585-591.
4. Boxall AM, Barclay L, Sayers A, Caplan GA. Managing chronic obstructive pulmonary disease in the community. A randomized controlled trial of home-based pulmonary rehabilitation for elderly housebound patients. J Cardiopulm Rehabil 2005; 25:378-385.
5. Coultas D, Frederick J, Barnett B, Singh G, Wludyka P. A randomized trial of two types of nurse-assisted home care for patients with copd. Chest 2005; 128:2017-2024.
6. Monninkhof E, van der Valk P, van der Palen J, van Herwaarden C, Zielhuis G. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J 2003; 22:815-820.
7. Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J 2004; 34:608-614.
8. Gallefoss F, Bakke PS, Rsgaard PK. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:812-817.
9. Gourley GA, Portner TS, Gourley DR, Rigolosi EL, Holt JM, Solomon DK, Bass GE, Wicke WR, Braden RL. Humanistic outcomes in the hypertension and copd arms of a multicenter outcomes study. J Am Pharm Assoc (Wash) 1998; 38:586-597.
10. Effing T, Monninkhof EM, van der Valk PD, van der Palen J, van Herwaarden CL, Partidge MR, Walters EH, Zielhuis GA. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007:CD002990.
11. Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003. Chest 2005;128:1179-1186.
12. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The st. George's respiratory questionnaire. Am Rev Respir Dis 1992;145:1321-1327.
13. Jones PW. St. George's respiratory questionnaire: Mcid. COPD 2005; 2:75-79.
14. Ware JE, Snow KK, Kosinski M. Sf-36 health survey: Manual and interpretation guide. Lincoln, RI: QualityMetric Incorporated; 2002.
15. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117:398S-401S.
16. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease (gold). Available at www.Goldcopd.Org. Accessed 7/17/07, 2006.
17. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356:775-789.
18. Spencer S, Calverley PM, Sherwood Burge P, Jones PW. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:122-128.
19. Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T, Jr. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002;19:217-224.
20. Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ, Jr., Kesten S, Towse L. A 6-month, placebo-controlled study comparing lung function and health status changes in copd patients treated with tiotropium or salmeterol. Chest 2002;122:47-55.
21. Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with copd. Thorax 2003;58:399-404.
22. Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA, Jr., Korducki L, Cassino C, Kesten S. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: A randomized trial. Ann Intern Med 2005;143:317-326.
23. Gadoury MA, Schwartzman K, Rouleau M, Maltais F, Julien M, Beaupre A, Renzi P, Begin R, Nault D, Bourbeau J. Self-management reduces both short- and long-term hospitalisation in copd. Eur Respir J 2005;26:853-857.
24. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med 2007; 167:551-561.
25. Gallefoss F, Bakke PS. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? Am J Respir Crit Care Med 1999; 160:2000-2005.
26. Watson PB, Town GI, Holbrook N, Dwan C, Toop LJ, Drennan CJ. Evaluation of a self-management plan for chronic obstructive pulmonary disease. Eur Respir J 1997; 10:1267-1271.
27. Niesink A, Trappenburg JC, de Weert-van Oene GH, Lammers JW, Verheij TJ, Schrijvers AJ. Systematic review of the effects of chronic disease management on quality-of-life in people with chronic obstructive pulmonary disease. Respir Med 2007; 101:2233-2239.
28. Blake RL, Jr., Vandiver TA, Braun S, Bertuso DD, Straub V. A randomized controlled evaluation of a psychosocial intervention in adults with chronic lung disease. Fam Med 1990; 22:365-370.
29. Howland J, Nelson EC, Barlow PB, McHugo G, Meier FA, Brent P, Laser-Wolston N, Parker HW. Chronic obstructive airway disease. Impact of health education. Chest 1986; 90:233-238.
30. Martin IR, McNamara D, Sutherland FR, Tilyard MW, Taylor DR. Care plans for acutely deteriorating copd: A randomized controlled trial. Chron Respir Dis 2004; 1:191-195.
31. Desikan R, Mason HL, Rupp MT, Skehan M. Health-related quality of life and healthcare resource utilization by copd patients: A comparison of three instruments. Qual Life Res 2002; 11:739-751.
32. Anie KA, Jones PW, Hilton SR, Anderson HR. A computer-assisted telephone interview technique for assessment of asthma morbidity and drug use in adult asthma. J Clin Epidemiol 1996; 49:653-656.